• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于 SEER 数据库的不同 PSA 水平远处转移性前列腺癌患者的风险因素分析和列线图构建研究。

Risk factor analysis and nomogram construction in patients with distant metastatic prostate cancer at different PSA levels: a study based on the SEER database.

机构信息

Department of Urology, Hebei Medical University Third Hospital, Shijiazhuang, China.

出版信息

Eur Rev Med Pharmacol Sci. 2024 Mar;28(6):2372-2386. doi: 10.26355/eurrev_202403_35744.

DOI:10.26355/eurrev_202403_35744
PMID:38567600
Abstract

OBJECTIVE

Prostate cancer (PCa) is the most common malignant tumor in the male genitourinary system. Once PCa has metastasized, it is very difficult to cure. The purpose of this study was to investigate the prognostic risk factor analysis of patients with different prostate-specific antigen (PSA) levels in distant metastatic PCa. At the same time, we construct effective models for predicting the survival rate of prostate cancer patients.

PATIENTS AND METHODS

Data on prostate cancer patients with the presence of distant metastases were obtained from the Surveillance, Epidemiology, and End Results (SEER) database. PCa patients with distant metastases were categorized into two groups based on PSA levels, one with PSA <20 ng/mL and the other with PSA ≥20 ng/mL. Univariate and multivariate COX regression analyses were used to identify independent factors affecting the prognosis of the patients. A nomogram was constructed using the independent prognostic factors, and the results were evaluated using calibration curves, timeROC curves, and Kaplan-Meier curves.

RESULTS

In the PSA <20 ng/mL group, there were a total of 1,832 patients. COX regression analysis showed that age, marital status, N stage, grade, Gleason score, and medical household income inflation were independent prognostic factors for overall survival (OS) in patients. In addition, we found that age, marital status, N stage, bone metastasis, grade, and Gleason score were independent prognostic factors for cancer-specific survival (CSS) in patients. In the PSA ≥20 ng/mL group, there were a total of 5,314 patients. It was found that age, ethnicity, marital status, bone metastasis, first malignant primary indicator, grade, Gleason score, and medical household income inflation were patients' independent prognostic factors for OS. For CSS, we found that age, ethnicity, marital status, T stage, radiotherapy, bone metastasis, Gleason score, and Median household income inflation were independent prognostic factors. Constructing a nomogram can accurately predict the prognosis of this group of patients.

CONCLUSIONS

We found different independent prognostic factors for different PSA levels in patients with distant metastatic PCa. A new nomogram was constructed to predict OS and CSS in patients, which helps in clinical-assisted decision-making.

摘要

目的

前列腺癌(PCa)是男性泌尿生殖系统中最常见的恶性肿瘤。一旦 PCa 发生转移,就很难治愈。本研究旨在探讨不同前列腺特异性抗原(PSA)水平的远处转移性 PCa 患者的预后风险因素分析。同时,构建预测前列腺癌患者生存率的有效模型。

方法

从监测、流行病学和最终结果(SEER)数据库中获取有远处转移的前列腺癌患者数据。根据 PSA 水平将远处转移的 PCa 患者分为两组,一组 PSA<20ng/mL,另一组 PSA≥20ng/mL。采用单因素和多因素 COX 回归分析确定影响患者预后的独立因素。使用独立预后因素构建列线图,并通过校准曲线、时间 ROC 曲线和 Kaplan-Meier 曲线进行评估。

结果

在 PSA<20ng/mL 组中,共有 1832 例患者。COX 回归分析显示,年龄、婚姻状况、N 分期、分级、Gleason 评分和医保家庭收入通胀是影响患者总生存期(OS)的独立预后因素。此外,我们发现年龄、婚姻状况、N 分期、骨转移、分级和 Gleason 评分是影响患者癌症特异性生存期(CSS)的独立预后因素。在 PSA≥20ng/mL 组中,共有 5314 例患者。结果发现,年龄、种族、婚姻状况、骨转移、第一恶性原发指标、分级、Gleason 评分和医保家庭收入通胀是影响 OS 的独立预后因素。对于 CSS,我们发现年龄、种族、婚姻状况、T 分期、放疗、骨转移、Gleason 评分和中等收入家庭收入通胀是独立的预后因素。构建列线图可以准确预测该组患者的预后。

结论

我们发现不同 PSA 水平的远处转移性 PCa 患者存在不同的独立预后因素。构建了一个新的列线图来预测患者的 OS 和 CSS,有助于临床辅助决策。

相似文献

1
Risk factor analysis and nomogram construction in patients with distant metastatic prostate cancer at different PSA levels: a study based on the SEER database.基于 SEER 数据库的不同 PSA 水平远处转移性前列腺癌患者的风险因素分析和列线图构建研究。
Eur Rev Med Pharmacol Sci. 2024 Mar;28(6):2372-2386. doi: 10.26355/eurrev_202403_35744.
2
Prognostic significance of surgery and radiotherapy in elderly patients with localized prostate cancer: establishing and time-based external validation a nomogram from SEER-based study.基于 SEER 研究的手术和放疗对局限性前列腺癌老年患者预后意义:建立和基于时间的外部验证nomogram。
BMC Urol. 2024 Jan 6;24(1):12. doi: 10.1186/s12894-023-01384-6.
3
Development and validation of a SEER-based prognostic nomogram for patients with bone metastatic prostate cancer.基于监测、流行病学和最终结果(SEER)数据库的骨转移性前列腺癌患者预后列线图的开发与验证
Medicine (Baltimore). 2019 Sep;98(39):e17197. doi: 10.1097/MD.0000000000017197.
4
Nomograms and scoring system for forecasting overall and cancer-specific survival of patients with prostate cancer.列线图和评分系统预测前列腺癌患者的总生存和癌症特异性生存。
Cancer Med. 2023 Feb;12(3):2600-2613. doi: 10.1002/cam4.5137. Epub 2022 Aug 22.
5
Development and validation of two nomograms for predicting overall survival and Cancer-specific survival in prostate cancer patients with bone metastases: a population-based study.开发和验证两种列线图,用于预测患有骨转移的前列腺癌患者的总生存和癌症特异性生存:一项基于人群的研究。
BMC Urol. 2023 Dec 5;23(1):200. doi: 10.1186/s12894-023-01372-w.
6
The prognostic nomogram for PSA-incongruent low-risk prostate cancer treated by radical prostatectomy.前列腺癌根治术治疗PSA不一致性低风险前列腺癌的预后列线图。
Int Urol Nephrol. 2023 Jun;55(6):1447-1452. doi: 10.1007/s11255-023-03560-x. Epub 2023 Apr 5.
7
Prognosis of prostate cancer and bone metastasis pattern of patients: a SEER-based study and a local hospital based study from China.基于 SEER 的研究与中国一家本地医院的研究:前列腺癌患者的预后与骨转移模式。
Sci Rep. 2020 Jun 4;10(1):9104. doi: 10.1038/s41598-020-64073-6.
8
Gleason score, surgical and distant metastasis are associated with cancer-specific survival and overall survival in middle aged high-risk prostate cancer: A population-based study.格里森评分、手术和远处转移与中年高危前列腺癌的癌症特异性生存和总生存相关:一项基于人群的研究。
Front Public Health. 2022 Oct 18;10:1028905. doi: 10.3389/fpubh.2022.1028905. eCollection 2022.
9
Nomogram for predicting the overall survival and cancer-specific survival of patients with intraductal carcinoma of the prostate.列线图预测前列腺导管内癌患者的总生存和癌症特异性生存。
J Cancer Res Clin Oncol. 2024 Jan 28;150(2):45. doi: 10.1007/s00432-023-05582-5.
10
Clinical characteristics analysis and prognostic nomogram for predicting survival in patients with second primary prostate cancer: a population study based on SEER database.基于 SEER 数据库的人群研究:预测第二原发前列腺癌患者生存的临床特征分析和预后列线图
J Cancer Res Clin Oncol. 2023 Oct;149(13):11791-11806. doi: 10.1007/s00432-023-05086-2. Epub 2023 Jul 5.